Sprinklr
CXM
5.19
+0.03
+0.58%
Sprinklr
US · CXM
#3122 by market cap
Listed 2021
5.19
+0.03
+0.58%
Live - 5344 symbols - heartbeat 358s ago
· 2026-10-08 06:25
Pre-market
5.16
-0.58%
After-hours
5.19
0.00%
- Market cap
- 1.20B
- P/E (TTM)i
- 51.90
- P/Bi
- 2.32
- EPSi
- 0.09
- Div yieldi
- 0.00%
- 52W posi
- 13%
Reader sentiment
Are you bullish or bearish on CXM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.50, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +7.64% YoY
Margins
- Gross margin
- 67.40%
- Operating margin
- 6.65%
- Net margin
- 2.67%
Key ratios & quality
- Altman Z-Scorei
- 1.50
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 324.28M | 386.93M | 492.39M | 618.19M | 732.36M | 796.39M | 857.20M |
| Gross profit | 201.12M | 264.85M | 344.84M | 454.47M | 552.96M | 574.64M | 577.78M |
| Selling & admin expenses | 204.17M | 250.15M | 371.72M | 429.03M | 423.45M | 456.23M | 424.76M |
| Research & development | 32.48M | 40.28M | 60.59M | 76.66M | 91.29M | 91.62M | 96.00M |
| Operating profit | -35.53M | -25.58M | -87.47M | -51.22M | 38.22M | 26.79M | 57.02M |
| Pretax profit | -36.46M | -34.19M | -104.55M | -47.47M | 60.52M | 48.29M | 66.79M |
| Tax | 3.33M | 3.78M | 6.92M | 8.27M | 9.12M | -73.32M | 43.88M |
| Net profit | -39.78M | -37.97M | -111.47M | -55.74M | 51.40M | 121.61M | 22.91M |
| Basic EPS | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.17 | -0.17 | -0.57 | -0.21 | 0.18 | 0.44 | 0.09 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 205.50M | 212.04M | 219.07M | 220.59M | 219.48M | 213.74M |
| Gross profit | 142.87M | 144.60M | 145.49M | 144.83M | 143.03M | 139.19M |
| Selling & admin expenses | 105.50M | 106.15M | 108.70M | 104.41M | 109.72M | 105.23M |
| Research & development | 22.81M | 23.16M | 24.71M | 25.32M | 23.36M | 24.43M |
| Operating profit | 14.56M | 15.29M | 12.08M | 15.10M | 9.96M | 9.53M |
| Pretax profit | 5.18M | 23.74M | 17.31M | 20.56M | 16.30M | 12.75M |
| Tax | 6.74M | 11.13M | 14.41M | 11.61M | 12.12M | 5.63M |
| Net profit | -1.57M | 12.62M | 2.90M | 8.95M | 4.18M | 7.12M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.01 | 0.05 | 0.01 | 0.04 | 0.02 | 0.03 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Total current assets | 184.60M | 498.06M | 805.26M | 862.53M | 1.00B | 854.10M | 887.98M |
| Cash & ST investments | 10.47M | 280.69M | 532.41M | 578.63M | 662.56M | 483.46M | 502.51M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 268.26M | 597.01M | 920.05M | 1.02B | 1.22B | 1.18B | 1.21B |
| Total current liabilities | 257.14M | 301.56M | 395.05M | 458.90M | 508.16M | 517.58M | 554.09M |
| Short-term debt | -- | -- | -- | 7.13M | 5.73M | 7.46M | 8.43M |
| Long-term debt | -- | 78.85M | -- | -- | -- | -- | -- |
| Total liabilities | 290,607,000.00 | 403,160,000.00 | 404,197,000.00 | 475,659,000.00 | 543,406,000.00 | 572,136,000.00 | 612,418,000.00 |
| Total equity | -22.35M | 193.85M | 515.85M | 549.33M | 679.70M | 612.06M | 592.64M |
| Retained earnings | -299.50M | -330.16M | -441.63M | -496.61M | -474.79M | -626.07M | -754.31M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 862.17M | 767.18M | 735.64M | 887.98M | 745.30M | 740.20M |
| Cash & ST investments | 570.23M | 473.99M | 480.35M | 502.51M | 442.81M | 452.90M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.19B | 1.09B | 1.05B | 1.21B | 1.06B | 1.05B |
| Total current liabilities | 495.49M | 493.92M | 444.06M | 554.09M | 519.90M | 476.00M |
| Short-term debt | 8.39M | 8.40M | 8.32M | 8.43M | 7.90M | 7.30M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 549,736,000.00 | 542,676,000.00 | 495,804,000.00 | 612,418,000.00 | 573,387,000.00 | 532,302,000.00 |
| Total equity | 639.77M | 543.44M | 558.09M | 592.64M | 488.46M | 519.48M |
| Retained earnings | -627.63M | -756.45M | -763.46M | -754.31M | -296.51M | -289.40M |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.97M | 7.31M | -32.92M | 26.66M | 71.47M | 77.59M | 159.19M |
| Depreciation & amortization | 4.42M | 5.69M | 8.06M | 12.05M | 15.47M | 18.68M | 19.06M |
| Free cash flow | 13.80M | 827.00K | -45.33M | 10.21M | 51.14M | 59.16M | 141.90M |
| Dividends paid | 0 | -600.00K | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -5.87M | 275.97M | 0 | -26.68M | -273.87M | -152.26M |
| Ending cash balance | 10.47M | 68.04M | 321.43M | 188.39M | 172.43M | 153.53M | 171.51M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 83.78M | 34.79M | 19.96M | 20.67M | 70.38M | 18.17M |
| Depreciation & amortization | 4.68M | 4.67M | 4.78M | 4.94M | 4.28M | 4.87M |
| Free cash flow | 80.70M | 29.75M | 15.26M | 16.19M | 65.82M | 13.12M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -140.85M | -11.42M | 0 | -125.00M | -796.00K |
| Ending cash balance | 135.10M | 133.83M | 198.06M | 171.51M | 171.87M | 240.07M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -81.49 | -10.47 | 8.36 | 18.83 | 3.80 |
| ROA %i | -14.82 | -9.78 | -14.80 | -5.73 | 4.57 | 10.10 | 1.92 |
| ROIC %i | -- | -- | -81.49 | -10.15 | 8.04 | 17.70 | 3.52 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -11.56 |
| EBIT margin %i | -10.96 | -7.44 | -17.76 | -8.29 | 4.64 | 3.01 | 6.65 |
| FCF / sales %i | 4.26 | 0.21 | -- | 1.65 | 6.98 | 7.43 | 16.55 |
| Current ratioi | 0.72 | 1.65 | 2.04 | 1.88 | 1.97 | 1.65 | 1.60 |
| Quick ratioi | 0.47 | 1.32 | 1.77 | 1.72 | 1.85 | 1.49 | 1.43 |
| Debt / assetsi | -- | 13.21 | 0.00 | 1.64 | 2.72 | 4.11 | 3.88 |
| LT debt / equityi | -- | -- | -- | 1.75 | 4.06 | 6.74 | 6.46 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 23.99 | 23.70 | 17.38 | 11.51 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -9.55 | 295.44 | -- | 140.42 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 17.50 | 23.74 | 21.35 | 3.80 | 5.08 | 4.36 |
| ROA %i | 9.46 | 11.61 | 11.13 | 1.92 | 2.55 | 2.17 |
| ROIC %i | 16.17 | 21.62 | 19.51 | 3.52 | 4.69 | 4.02 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.07 | 5.41 | 5.89 | 6.65 | 6.02 | 5.35 |
| FCF / sales %i | 12.83 | 14.21 | 15.16 | 16.55 | 14.58 | 12.65 |
| Current ratioi | 1.74 | 1.55 | 1.66 | 1.60 | 1.43 | 1.56 |
| Quick ratioi | 1.57 | 1.39 | 1.45 | 1.43 | 1.25 | 1.46 |
| Debt / assetsi | 4.28 | 4.44 | 4.60 | 3.88 | 4.13 | 3.93 |
| LT debt / equityi | 6.65 | 7.33 | 7.19 | 6.46 | 7.36 | 6.56 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:25:52 · For reference only, not investment advice and not tailored to your situation.